162 related articles for article (PubMed ID: 18413158)
1. The incidence of heart failure among nondiabetic patients with and without impaired fasting glucose.
Nichols GA; Koro CE; Kolatkar NS
J Diabetes Complications; 2009; 23(3):224-8. PubMed ID: 18413158
[TBL] [Abstract][Full Text] [Related]
2. Normal fasting plasma glucose and risk of type 2 diabetes diagnosis.
Nichols GA; Hillier TA; Brown JB
Am J Med; 2008 Jun; 121(6):519-24. PubMed ID: 18501234
[TBL] [Abstract][Full Text] [Related]
3. [What will be the proper criteria for impaired fasting glucose for Korean men? Based on medical screening data from a general hospital].
Ryu S; Chang YS; Kim DI; Suh BS; Kim WS
J Prev Med Public Health; 2005 May; 38(2):203-7. PubMed ID: 16315759
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of fasting plasma glucose to predict mortality or coronary heart disease in persons > or = 60 years of age without diabetes mellitus or in those with undiagnosed diabetes mellitus (from The Dubbo Study).
Simons LA; Simons J; Friedlander Y; McCallum J
Am J Cardiol; 2008 Oct; 102(7):831-4. PubMed ID: 18805106
[TBL] [Abstract][Full Text] [Related]
5. The sequential changes in the fasting plasma glucose levels within normoglycemic range predict type 2 diabetes in healthy, young men.
Park YW; Chang Y; Sung KC; Ryu S; Sung E; Kim WS
Diabetes Res Clin Pract; 2006 Sep; 73(3):329-35. PubMed ID: 16600415
[TBL] [Abstract][Full Text] [Related]
6. Novel metabolic risk factors for heart failure.
Ingelsson E; Arnlöv J; Sundström J; Zethelius B; Vessby B; Lind L
J Am Coll Cardiol; 2005 Dec; 46(11):2054-60. PubMed ID: 16325042
[TBL] [Abstract][Full Text] [Related]
7. [Prognostic importance of abnormal glucose metabolism in chronic heart failure].
Guo JC; Li ZP; Gao W; Guo YH; Mao JM
Zhonghua Yi Xue Za Zhi; 2010 May; 90(20):1385-8. PubMed ID: 20646626
[TBL] [Abstract][Full Text] [Related]
8. Value and significance of new diagnostic criteria of diabetes mellitus in older people.
Motta M; Bennati E; Ferlito L; Passamonte M; Malaguarnera M
Arch Gerontol Geriatr; 2007; 45(1):103-8. PubMed ID: 17140679
[TBL] [Abstract][Full Text] [Related]
9. Early prediction of new-onset diabetes mellitus by fifth-day fasting plasma glucose, pulse pressure, and proteinuria.
Rodrigo E; Santos L; Piñera C; Quintanar JA; Ruiz JC; Fernández-Fresnedo G; Palomar R; Gómez-Alamillo C; Arias M
Transplant Proc; 2011; 43(6):2208-10. PubMed ID: 21839235
[TBL] [Abstract][Full Text] [Related]
10. Fasting plasma glucose and incident heart failure risk: a population-based cohort study and new meta-analysis.
Khan H; Kunutsor SK; Kauhanen J; Kurl S; Gorodeski EZ; Adler AI; Butler J; Laukkanen JA
J Card Fail; 2014 Aug; 20(8):584-92. PubMed ID: 24928433
[TBL] [Abstract][Full Text] [Related]
11. The association of fasting glucose levels with congestive heart failure in diabetic adults > or =65 years: the Cardiovascular Health Study.
Barzilay JI; Kronmal RA; Gottdiener JS; Smith NL; Burke GL; Tracy R; Savage PJ; Carlson M
J Am Coll Cardiol; 2004 Jun; 43(12):2236-41. PubMed ID: 15193686
[TBL] [Abstract][Full Text] [Related]
12. Diabetes in heart failure: prevalence and impact on outcome in the population.
From AM; Leibson CL; Bursi F; Redfield MM; Weston SA; Jacobsen SJ; Rodeheffer RJ; Roger VL
Am J Med; 2006 Jul; 119(7):591-9. PubMed ID: 16828631
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of high fasting plasma glucose and risk of developing end-stage renal disease in screened subjects in Okinawa, Japan.
Iseki K; Ikemiya Y; Kinjo K; Iseki C; Takishita S
Clin Exp Nephrol; 2004 Sep; 8(3):250-6. PubMed ID: 15480903
[TBL] [Abstract][Full Text] [Related]
14. Smoking and development of type 2 diabetes in patients with decreased functional capacity.
Tenenbaum A; Fisman EZ; Adler Y; Motro M; Boyko V; Behar S
Int J Cardiol; 2005 Oct; 104(3):275-81. PubMed ID: 16186056
[TBL] [Abstract][Full Text] [Related]
15. Impact of impaired fasting glucose on cardiovascular disease: the Framingham Heart Study.
Levitzky YS; Pencina MJ; D'Agostino RB; Meigs JB; Murabito JM; Vasan RS; Fox CS
J Am Coll Cardiol; 2008 Jan; 51(3):264-70. PubMed ID: 18206734
[TBL] [Abstract][Full Text] [Related]
16. Influence of diabetes on characteristics and outcomes in patients hospitalized with heart failure: a report from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).
Greenberg BH; Abraham WT; Albert NM; Chiswell K; Clare R; Stough WG; Gheorghiade M; O'Connor CM; Sun JL; Yancy CW; Young JB; Fonarow GC
Am Heart J; 2007 Aug; 154(2):277.e1-8. PubMed ID: 17643576
[TBL] [Abstract][Full Text] [Related]
17. Fasting glucose cutoff point: where does the risk terminate? Tehran lipid and glucose study.
Bozorgmanesh M; Hadaegh F; Saadat N; Azizi F
Acta Diabetol; 2012 Oct; 49(5):341-8. PubMed ID: 21617883
[TBL] [Abstract][Full Text] [Related]
18. Blood glucose and cerebrovascular disease in nondiabetic patients.
Nielson C; Fleming RM
Angiology; 2007; 58(5):625-9. PubMed ID: 18024949
[TBL] [Abstract][Full Text] [Related]
19. Detection of undiagnosed diabetes and prediabetic states in high-risk emergency department patients.
Charfen MA; Ipp E; Kaji AH; Saleh T; Qazi MF; Lewis RJ
Acad Emerg Med; 2009 May; 16(5):394-402. PubMed ID: 19302369
[TBL] [Abstract][Full Text] [Related]
20. Admission blood glucose level and mortality among hospitalized nondiabetic patients with heart failure.
Barsheshet A; Garty M; Grossman E; Sandach A; Lewis BS; Gottlieb S; Shotan A; Behar S; Caspi A; Schwartz R; Tenenbaum A; Leor J
Arch Intern Med; 2006 Aug 14-28; 166(15):1613-9. PubMed ID: 16908794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
